<DOC>
	<DOC>NCT01577563</DOC>
	<brief_summary>RATIONAL is a multinational, multicentre, observational, cross sectional study of adult patients in treatment with NSAID therapy for OA, RA or AS during for at least 2 weeks before study visit (at least one dose).</brief_summary>
	<brief_title>Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).</brief_title>
	<detailed_description>Prevalence study of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving treatment with non- steroidal anti- inflammatory drugs.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<criteria>Provision of subject informed consent. Female and/or male, aged &gt; 21 years. Patients diagnosis with RA (ACR 1987 or ACR/EULAR 2010 criteria), OA (ACR 1986, 1990 and 1991 criteria) or AS (New York 1984 criteria or ESSG 2002 criteria) (documented in the medical record). Patients receiving at least one dose of NSAIDs. Participation in any interventional study involving investigational drugs. Patient refuses to fill in the study questionnaires. Pregnant or breastfeeding women. Patients with active neoplastic disease in the last 5 years, except basalcell carcinoma.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>osteoarthritis (OA)</keyword>
	<keyword>rheumatoid arthritis (RA)</keyword>
	<keyword>ankylosing spondylitis (AS)</keyword>
	<keyword>gastrointestinal risk factors</keyword>
	<keyword>NSAIDs</keyword>
</DOC>